Albiflorin suppresses breast cancer via the HINT2/NLRP3 signaling pathway.

Hu Y, Li C, Cui Y

Open source

DOI: 10.36721/pjps.2026.39.12.348.1
Published: 2026 Dec 1
Container: Pakistan journal of pharmaceutical sciences
Publisher: Not recorded
Open access: no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.36721/pjps.2026.39.12.348.1,
  title = {Albiflorin suppresses breast cancer via the HINT2/NLRP3 signaling pathway.},
  author = {Hu Y and Li C and Cui Y},
  year = {2026},
  journal = {Pakistan journal of pharmaceutical sciences},
  doi = {10.36721/pjps.2026.39.12.348.1},
  url = {https://doi.org/10.36721/pjps.2026.39.12.348.1}
}

RIS

TY  - JOUR
TI  - Albiflorin suppresses breast cancer via the HINT2/NLRP3 signaling pathway.
AU  - Hu Y
AU  - Li C
AU  - Cui Y
PY  - 2026
JO  - Pakistan journal of pharmaceutical sciences
DO  - 10.36721/pjps.2026.39.12.348.1
UR  - https://doi.org/10.36721/pjps.2026.39.12.348.1
ER  -

APA

Y, H., C, L., & Y, C. (2026). Albiflorin suppresses breast cancer via the HINT2/NLRP3 signaling pathway.. Pakistan journal of pharmaceutical sciences. https://doi.org/10.36721/pjps.2026.39.12.348.1

Source records

pubmed · retrieved 2026-09-26T02:30:48.736Z
europe-pmc · retrieved 2026-09-26T02:30:48.753Z
doaj · retrieved 2026-09-26T02:30:48.777Z